Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Dec 21;7(12):e018302.
doi: 10.1136/bmjopen-2017-018302.

Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes

Xiqian Huo  1 , Erica S Spatz  2 , Qinglan Ding  2 , Paul Horak  2 , Xin Zheng  1 , Claire Masters  2 , Haibo Zhang  1 , Melinda L Irwin  2 , Xiaofang Yan  1 , Wenchi Guan  1 , Jing Li  1 , Xi Li  1 , John A Spertus  3 , Frederick A Masoudi  4 , Harlan M Krumholz  2 , Lixin Jiang  1
Affiliations
Randomized Controlled Trial

Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes

Xiqian Huo et al. BMJ Open. .

Erratum in

Abstract

Introduction: Mobile health interventions have the potential to promote risk factor management and lifestyle modification, and are a particularly attractive approach for scaling across healthcare systems with limited resources. We are conducting two randomised trials to evaluate the efficacy of text message-based health messages in improving secondary coronary heart disease (CHD) prevention among patients with or without diabetes.

Methods and analysis: The Cardiovascular Health And Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study are multicentre, single-blind, randomised controlled trials of text messaging versus standard treatment with 6 months of follow-up conducted in 37 hospitals throughout 17 provinces in China. The intervention group receives six text messages per week which target blood pressure control, medication adherence, physical activity, smoking cessation (when appropriate), glucose monitoring and lifestyle recommendations including diet (in CHAT-DM). The text messages were developed based on behavioural change techniques, using models such as the information-motivation-behavioural skills model, goal setting and provision of social support. A total sample size of 800 patients would be adequate for CHAT Study and sample size of 500 patients would be adequate for the CHAT-DM Study. In CHAT, the primary outcome is the change in systolic blood pressure (SBP) at 6 months. Secondary outcomes include a change in proportion of patients achieving a SBP <140 mm Hg, low-density lipoprotein cholesterol (LDL-C), physical activity, medication adherence, body mass index (BMI) and smoking cessation. In CHAT-DM, the primary outcome is the change in glycaemic haemoglobin (HbA1C) at 6 months. Secondary outcomes include a change in the proportion of patients achieving HbA1C<7%, fasting blood glucose, SBP, LDL-C, BMI, physical activity and medication adherence.

Ethics and dissemination: The central ethics committee at the China National Center for Cardiovascular Disease and the Yale University Institutional Review Board approved the CHAT and CHAT-DM studies. Results will be disseminated via usual scientific forums including peer-reviewed publications.

Trial registration number: CHAT (NCT02888769) and CHAT-DM (NCT02883842); Pre-results.

Keywords: behavioral intervention; coronary heart disease; diabetes; secondary prevention; text messaging.

PubMed Disclaimer

Conflict of interest statement

Competing interests: HMK is a recipient of research agreements from Medtronic and Johnson & Johnson (Janssen) through Yale University to develop methods of clinical trial data sharing. He is also the recipient of a grant from the Food and Drug Administration and Medtronic to develop methods for postmarket surveillance of medical devices; and is the founder of Hugo, a personal health information platform. All other authors have no conflicts of interests to declare.

Figures

Figure 1
Figure 1
Geographical distribution of sites in the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (DM) Study.
Figure 2
Figure 2
Text development process. AHA, American Heart Association; BCT, behavioural change techniques; CHAT, Cardiovascular Health And Text Messaging; CVD, Cardiovascular Disease; DM, diabetes mellitus.
See this image and copyright information in PMC

References

    1. Gaede PH, Jepsen PV, Larsen JN, et al. . [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskr Laeger 2003;165:2658–61. - PubMed
    1. Clark AM, Hartling L, Vandermeer B, et al. . Secondary prevention programmes for coronary heart disease: a meta-regression showing the merits of shorter, generalist, primary care-based interventions. Eur J Cardiovasc Prev Rehabil 2007;14:538–46. 10.1097/HJR.0b013e328013f11a - DOI - PubMed
    1. Suaya JA, Shepard DS, Normand SL, et al. . Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 2007;116:1653–62. 10.1161/CIRCULATIONAHA.107.701466 - DOI - PubMed
    1. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008;117:1028–36. 10.1161/CIRCULATIONAHA.107.706820 - DOI - PubMed
    1. Akincigil A, Bowblis JR, Levin C, et al. . Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction. J Gen Intern Med 2008;23:115–21. 10.1007/s11606-007-0351-9 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data